Icon times
Krsnaa Diagnostics

Krsnaa Diagnostics

CompanyOver

 / 
 
 

About

Highlights

Performing rate for the company

Track the companies of Group.

Relaince Group

Sector: Refineries

Market Price

2,529.50

Market Cap(₹Cr.)

2,529.50

-90.00

Quarterly Results ( Figures in Rs. Crores.)

No Data is available.

Profit & Loss ( Figures in Rs. Crores.)

No Data is available.

Balance Sheet ( Figures in Rs. Crores.)

No Data is available.

Cash Flows ( Figures in Rs. Crores.)

No Data is available.

Historical Growths

Compounded Sales Growth
Compounded Profit Growth
Compounded Expense Growth
Stock Price CAGR
No data is available
Sales Growth Profit Growth Expense Growth Stock Price CAGR

Ratios ()

No Data is available.

Major Shareholders

No Data is available.

Shareholders more than 1%

No Data is available.

Fund houses invested in the stock (Figures in % Equity Capital )

No Data is available.

Corporate Action

No Data is available.
No Data is available.
No Data is available.
No Data is available.

Documents

Presentation & Earning Calls

Annual Reports

Credit Rating

No document is available
No document is available
No document is available
No document is available.

Overview

Krsnaa Diagnostics is one of the largest differentiated diagnostic service provider in India. It provides a range of technology-enabled diagnostic services such as imaging (including radiology), pathology/clinical laboratory and tele-radiology services to public and private hospitals, medical colleges and community health centres pan-India. It also operate one of India’s largest tele-radiology reporting hubs in Pune that is able to process large volumes of X-rays, CT scans and MRI scans round the clock and 365 days a year, and allows it to serve patients in remote locations where diagnostic facilities are limited. It provides quality and inclusive diagnostic services at affordable rates across various segments.

The company offers range of diagnostics imaging services and clinical laboratory tests that include both routine and specialized tests / studies and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases. Its diagnostic imaging/radiology services include conducting X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, ultrasounds, bone mineral densitometry and mammography. In its pathology segment, its primary focus includes biochemistry, haematology, clinical pathology, histopathology and cytopathology, microbiology, serology and immunology. A suite of diagnostic equipment is located at its tele-radiology hub along with a team of radiologists which provide it significant operating efficiencies and scalability.

Business area of the company

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres.

Key awards, accreditations or recognitions

  • 2016: Star of Asia Award for Health Excellence at the 10th International Seminar of the Indian Achievers Forum.
  • 2017: Emerging Company Award for Health Excellence at the 42nd National Seminar of the Indian Achiever’s Awards.
  • 2019: India’s Greatest Brands Award for Healthcare and Diagnostics by Asia One.
  • 2020: Best Diagnostic and Imaging Centre of the Year (Asia) at the Asia Healthcare Summit and Awards.
  • 2020: Best Diagnostics Service Company of the Year at the India Excellence Awards by ET Now.
  • 2020: Outstanding Achievement Award in Healthcare Social Causes at the India Excellence Awards by ET Now.

Major events and milestones

  • 2011: Incorporation of the company with two radiology centres.
  • 2013: Started operating 12 centres in Himachal Pradesh in public private partnership.
  • 2016: Investment by Somerset and Kitara in the Company.
  • 2017: Completed installation of 50 centres in four states.
  • 2018: Expanded operations across 13 states.
  • 2019: Received accreditation from NABH for a centre in Madhya Pradesh.
  • 2019: Investment by Phi Capital in the company.
  • 2020 Received accreditation from NABH and NABL for certain centres in Maharashtra.
  • 2020: Expanded to over 1,500 centres across India.
  • 2020: Received accreditation from NABL for certain centres in Rajasthan.
Brands Of Krsnaa Diagnostics

Brands Of Krsnaa Diagnostics

undefined

Comment

Chat on WhatsApp
Caret UP Arrow
InvestYadnya Support
Typically replies in minutes
InvestYadnya Support
Hi there
Welcome to InvestYadnya.
We are available to assist you on WhatsApp.
Please click on the button below to chat with us.
(10 AM to 7 PM IST)
16:10
Chat with InvestYadnya